Hypomania

  1. home
  2. blog
  3. Hypomania

Development of Cannabis-Based Treatment for Bipolar Disorder

June 30, 2019 , , , , , , , , , , , , , , , , , , , , ,

Bipolar disorder and the endocannabinoid system

A recently published article serves as a call for research to be conducted to discover how cannabis could impact the management of bipolar disorder (BD). Presented in the article is a full review of the advantages and disadvantages of cannabis-based medicine in the treatment of BD and provides insight into possible mechanisms might affect the pathophysiology of the disorder. The insights listed within the article provide the rationale for examining the endocannabinoid system, specifically the cannabinoid receptor 2, with the hopes of finding therapeutic targets for mood control associated with BD.  

View this review (yellow link) or download:

Bipolar disorder and the endocannabinoid systemDownload

This paper is also stored here:   http://bit.ly/2FfJXK6      inside the CED Foundation Archive

To explore related information, click the keywords below:

Benjamin Caplan, MDDevelopment of Cannabis-Based Treatment for Bipolar Disorder
read more

High-potency cannabis and incident psychosis: correcting the causal assumption

June 15, 2019 , , , , , , , , , , , , , , , ,

Scientists offer a strong counter-position to the belief that cannabis causes psychosis, pointing out the difference between correlation and causation. They argue that smoke exposure from any source (including cigarettes) could explain the reported link between cannabis and psychosis. 

View this review (yellow link) or download:

High-potency cannabis and incident psychosis- correcting the causal assumptionDownload

This paper is also stored here:    http://bit.ly/2WHtDr8     inside the CED Foundation Archive

To explore related information, click keywords below:

Benjamin Caplan, MDHigh-potency cannabis and incident psychosis: correcting the causal assumption
read more

Dronabinol use in a patient with Bipolar Disorder

June 5, 2019 , , ,

Dronabinol-Induced Hypomania: A Case Report and Literature Review
An HIV patient who also suffers from bipolar disorder was administered dronabinol, a synthetic cannabis alternative. Following a dosage increase, the previously stable patient presented to his psychiatrist in a state of hypomania. Although this singular case study cannot be used to make any definitive conclusion, it underscores the need for further research surrounding the effects of cannabis on mood

http://bit.ly/2W275Bb

Benjamin Caplan, MDDronabinol use in a patient with Bipolar Disorder
read more